comparemela.com

Lindsayh Burns News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cassava Sciences : Corporate Presentation – First Quarter 2024 -March 25, 2024 at 09:36 am EDT

Corporate Overview First Quarter 2024 Forward-Looking Statements & Other Notices Cassava Sciences is in the business of new drug discovery.

Remi barbierMichael marsmanLindsayh burnsMichael zamlootChris cookJim kupiecEric schoenRegulatory affairsIntroduction to cassava sciencesCassava sciencesNational institutes of healthDiscovery development programCorporate overview first quarterAnnual reportPrivate securities litigation reform actNational institutes

CUNY Halts Investigation of Alzheimer s Researcher

Citing questions about the integrity of the process, the university said that “no final action” had been taken.

United statesNew yorkRemi barbierLindsayh burnsHoau yan wangExchange commissionCassava sciencesNational institutes of healthCity university of new yorkCity universityNational institutesYour feed scienceEthics misconduct malfeasanceAlzheimer x27 sClinical trial

Scientists Investigating Alzheimer s Drug Faulted in Leaked Report

A professor at the City College of New York engaged in “significant research misconduct,” an expert committee concluded.

United statesNew yorkHoau yan wangLindsayh burnsDee mozeleskiRemi barbierExchange commissionDrug administrationCity collegeOffice of research integrityCity university of new yorkCassava sciencesCity college of new yorkNational institutes of healthCity universityNational institutes

Scientists Question Data Behind an Experimental Alzheimer s Drug

Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.

University collegeNew south walesUnited statesNew yorkSan diegoSan franciscoUniversity of texas at san antonioHoau yan wangRemi barbierGeorge perryRobert howardGeoffrey pittRoger nicollDavid vauxDavid bredtLindsayh burns

vimarsana © 2020. All Rights Reserved.